Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A Randomized Phase II Trial of Dasatinib 100 Mg Vs Imatinib 400 Mg In Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP): The S0325 Intergroup Trial

Jerald P. Radich, MD, Kenneth J. Kopecky, PhD, Suzanne Kamel-Reid, PhD, Wendy Stock, MD, Elisabeth Paietta, PhD, Martha Wadleigh, MD, Richard A. Larson, MD, Peter D. Emanuel, MD, Martin S. Tallman, MD, Jeffrey Lipton, MD, FRCPC, Stephen Couban, BSc, MD, Michael W. Deininger, MD, PhD, Frederick R. Appelbaum, MD, Brian J. Druker, MD

Blood (2010) 116 (21): LBA-6.

https://doi.org/10.1182/blood.V116.21.LBA-6.LBA-6

Published: 2010

Journal Articles

No Significance of Derivative Chromosome 9 Deletion on the Clearance Kinetics of BCR/ABL Fusion Transcripts, Cytogenetic or Molecular Response, Loss of Response or Treatment Failure to Imatinib Mesylate Therapy for Chronic Myeloid Leukemia.

Dong Hwan (Dennis) Kim, MD, PhD, Lakshmi Sriharsha, Suzanne Kamel-Reid, MD, PhD, Hong Chang, MD, Hans Messner, MD, PhD, Jeffrey Lipton, MD, PhD

Blood (2007) 110 (11): 1950.

https://doi.org/10.1182/blood.V110.11.1950.1950

Published: 2007

Journal Articles

Megakaryocytes Cultured from Patients with IMF Produced Significantly Higher mRNA but Not Protein Levels of Fibrosing Grown Factors.

Jen-Chin Wang, MD, Tsong H Chang, MD, Amit Goldberg, MD, Allan D. Novetsky, MD, Steven Lichter, MD, Jeffrey Lipton, MD

Blood (2006) 108 (11): 3607.

https://doi.org/10.1182/blood.V108.11.3607.3607

Published: 2006

Journal Articles

Factors Influencing Varicella-Zoster Virus (VZV) Infection after Allogeneic Peripheral Blood Stem Cell Transplantation: Low-Dose Acyclovir Prophylaxis and Pre-Transplant Diagnosis of Lymphoproliferative Disorders.

Dong Hwan Kim, MD, PhD, Hans Messner, MD, PhD, Vikas Gupta, MD, MRCP, John Kuruvilla, MD, Janice Wright, MS, ACNP(C), Jeffrey Lipton, MD, PhD

Blood (2006) 108 (11): 3373.

https://doi.org/10.1182/blood.V108.11.3373.3373

Published: 2006

Journal Articles

Quantitative Analysis of Growth Factor Production in the Mechanism of Fibrosis in Agnogenic Myeloid Metaplasia.

Jen-Chin Wang, MD, Tsong S. Chang, MD, Amit Goldberg, MD, Allan D. Novetsky, MD, Jeffrey Lipton, MD

Blood (2005) 106 (11): 4272.

https://doi.org/10.1182/blood.V106.11.4272.4272

Published: 2005

Journal Articles

Dissecting Growth Factors Production in Patients with Agnogenic Myeloid Metaplasia (AMM).

Jen-Chin Wang, MD, Kirugaval Hemavathy, Ph.D, Amit Goldberg, M.D, Tsong S. Chang, MD, Allan D. Novetsky, MD, Jeffrey Lipton, MD

Blood (2004) 104 (11): 4749.

https://doi.org/10.1182/blood.V104.11.4749.4749

Published: 2004

NARROW

A Randomized Phase II Trial of Dasatinib 100 Mg Vs Imatinib 400 Mg In Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP): The S0325 Intergroup Trial

No Significance of Derivative Chromosome 9 Deletion on the Clearance Kinetics of BCR/ABL Fusion Transcripts, Cytogenetic or Molecular Response, Loss of Response or Treatment Failure to Imatinib Mesylate Therapy for Chronic Myeloid Leukemia.

Megakaryocytes Cultured from Patients with IMF Produced Significantly Higher mRNA but Not Protein Levels of Fibrosing Grown Factors.

Factors Influencing Varicella-Zoster Virus (VZV) Infection after Allogeneic Peripheral Blood Stem Cell Transplantation: Low-Dose Acyclovir Prophylaxis and Pre-Transplant Diagnosis of Lymphoproliferative Disorders.

Quantitative Analysis of Growth Factor Production in the Mechanism of Fibrosis in Agnogenic Myeloid Metaplasia.

Dissecting Growth Factors Production in Patients with Agnogenic Myeloid Metaplasia (AMM).

Email alerts

ASH Publications

American Society of Hematology

A Randomized Phase II Trial of Dasatinib 100 Mg Vs Imatinib 400 Mg In Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP): The S0325 Intergroup Trial

No Significance of Derivative Chromosome 9 Deletion on the Clearance Kinetics of BCR/ABL Fusion Transcripts, Cytogenetic or Molecular Response, Loss of Response or Treatment Failure to Imatinib Mesylate Therapy for Chronic Myeloid Leukemia.

Megakaryocytes Cultured from Patients with IMF Produced Significantly Higher mRNA but Not Protein Levels of Fibrosing Grown Factors.

Factors Influencing Varicella-Zoster Virus (VZV) Infection after Allogeneic Peripheral Blood Stem Cell Transplantation: Low-Dose Acyclovir Prophylaxis and Pre-Transplant Diagnosis of Lymphoproliferative Disorders.

Quantitative Analysis of Growth Factor Production in the Mechanism of Fibrosis in Agnogenic Myeloid Metaplasia.

Dissecting Growth Factors Production in Patients with Agnogenic Myeloid Metaplasia (AMM).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only